Alphabiome Ai
Alphabiome is pioneering a new approach to decoding the microbiome and predicting drug response using advanced AI. Our platform delivers proprietary, IP-protected biomarkers backed by robust human data, ready for direct licensing. Founded by MIT AI experts and Stanford Nobel Laureates in genetics, the company has already discovered over novel biomarkers. The technology has been validated in large-scale animal trials and shown proof-of-concept in humans, with recent breakthroughs in predicting drug efficacy for Crohn’s and Colitis.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
10
11 to 50 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Alphabiome Ai
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Alphabiome Ai
5 distinct titles indexed · top 5 shown.
- 1business operations manager
- 1director of finance & business operations
- 1full stack developer
- 1microbiome research scientist
- 1vp for product strategy & partnerships
Sign up to unlock all 5 contacts at Alphabiome Ai
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Alphabiome Ai
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.